Month: April 2020

GREENSBORO, N.C., April 13, 2020 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG), a leading food distributor to Asian restaurants across the Southeast, Pacific and Mountain West regions of the United States (the “Company”), announced that in light of COVID-19 impacts to its local communities, it donated nearly 400 tons of fruits and vegetables to food banks within North Carolina, Georgia and Florida in the past two weeks. The company has also donated masks and gloves to hospitals near its Los Angeles operations center.“We want to help our neighbors in any way we can in this difficult time,” said Joann Lam, president of HF Foods subsidiary Han Feng, Inc. and one of the founders of HF Foods Group. “The company is glad to have been able to donate more than a half million dollars’ worth of food to support the local nonprofit agencies...

Educational awareness forum to feature leading experts in discussions on risk adaptive tools and pragmatic solutions to enhance patient care during COVID-19 pandemicEvent kicks off series of informational webinars featuring breast cancer thought leaders sharing best practices using leading-edge technologies in cancer detection and treatmentNASHUA, N.H., April 13, 2020 (GLOBE NEWSWIRE) —  iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it has partnered with the TME Breast Care Network to host a free virtual roundtable event for clinicians, titled “Breast Care Roundtable in the Age of COVID-19,” on April 21, 2020 at 7 pm ET/4 pm PT. To register for the event, visit this link: https://bit.ly/2UNdXoG.“Our goal with this collective effort...

DENVER, April 13, 2020 (GLOBE NEWSWIRE) — Business intelligence from Akerna (Nasdaq: KERN), a leading compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®) in collaboration with *Ample Organics, shows, year-over-year, spirits sales have increased 32%. According to market insights from Ample Organics, Gin sales topped that growth with a year-over-year increase of 55% in March. This is among the few times where stronger growth in the basics like Gin at 55%, Rum at 38%, and Vodka at 36% has been seen. Tequila, recently a category leader, fell to sixth place with 18%. Some theories suggest consumers are turning to basics because of attractive price points per liter against more fancy and differentiated spirits. Business intelligence...

TORONTO, April 13, 2020 (GLOBE NEWSWIRE) — Altus Group Limited (“Altus Group” or the “Company”) (TSX: AIF) announced today that it will now hold its upcoming annual and special meeting of shareholders (the “Meeting”) on May 6, 2020 at 11:00 a.m. (Toronto time) in a virtual only format whereby shareholders may attend and participate in the Meeting via live audio webcast.The Meeting was previously scheduled to be held at the offices of Stikeman Elliott LLP. In order to address the unprecedented public health impact of the COVID-19 (coronavirus) disease and to mitigate risks to the health and safety of communities, shareholders, employees and other stakeholders, Altus Group will now hold its Meeting in a virtual only format, which will be conducted via live audio webcast. All shareholders, regardless of geographic location and equity...

LAFAYETTE, La., April 13, 2020 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced that it supports the recent decision by the Centers for Medicare and Medicaid Services (CMS), due to the novel COVID-19 pandemic, to remove non-invasive ventilators (NIV) from the next round of the Competitive Bidding Program (CBP) that was expected to begin in 2021, as the Company believes that the inclusion of this life saving device in the program could have had a negative outcome on patient care that is predicated on frequent and substantial service.The Company had prepared for the CBP over the last year, and had submitted bids in a majority of the areas around the country.  The Company...

SANTA CLARA, Calif., April 13, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the company has completed enrollment in their DISRUPT CAD IV study of IVL in heavily calcified coronary arteries that is intended to support regulatory device approval in Japan.DISRUPT CAD IV is a prospective, multicenter, single-arm confirmatory study that enrolled 64 patients in eight sites across Japan to demonstrate the safety and effectiveness of the Shockwave Coronary IVL System with the Shockwave C2 IVL Catheter in the treatment of de novo, calcified, stenotic, coronary arteries prior to stenting.“The fact that we were able to enroll this study in only five months showcases the potential value that...

CINCINNATI, April 13, 2020 (GLOBE NEWSWIRE) — Protech Home Medical Corp. (the “Company” or “Protech”) (TSXV: PTQ), a healthcare services company with operations in the U.S., provides a further business update on its operations during the COVID-19 pandemic.Protech provides home delivery and efficient online set-up of equipment for, primarily, chronic conditions. The Company, based in the United States, operates out of 42 locations in 10 states with over 17,000 referring physicians and approximately 80,000 current active patients.“In just a few weeks, our business has settled into a new normal,” commented Greg Crawford, Chairman and CEO of Protech. “As we noted in our press release dated March 18, 2020, our business has been deemed essential by the US government and we continue full operations during this pandemic. Since then, we have...

TORONTO, April 13, 2020 (GLOBE NEWSWIRE) — Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), is pleased to announce it has hired technology industry veteran Dietmar Wennemer as the Company’s new Chief Operating Officer (COO) and President.  Mr. Wennemer will begin his role on Monday the 13th of April 2020 at the Company’s Toronto Headquarters, and be responsible for leading the product development and operations efforts.  Mr. Wennemer will report to the Company’s CEO Martin Cronin, who will focus his efforts in corporate and business development, as well as investor and external communications.  “As we expand the commercialization of our PATSCAN Multi-Sensor Covert Threat Detection Platform in 2020, hiring a tech industry veteran like Dietmar as our Chief Operating Officer...

SALT LAKE CITY, April 13, 2020 (GLOBE NEWSWIRE) — Predictive Biotech, a wholly owned subsidiary of Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), announced that on April 9th it submitted an Emergency Use Authorization (EUA) application with the U.S. Food and Drug Administration (FDA) for the immediate use of mesenchymal stem cells (MSCs) derived from umbilical cord tissue for the treatment of Acute Respiratory Distress Syndrome (ARDS), secondary to SARS-CoV-2, coronavirus disease 2019 (COVID-19).The pandemic caused by COVID-19 has shown to develop into severe ARDS in 30% of hospitalized patients with a 22%-62% mortality rate (Murthy et al., 2020) for those requiring hospitalization in an intensive care unit. Currently, there is no confirmed treatment that can demonstrate safety or efficacy for the...

GERMANTOWN, Md., April 13, 2020 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering, global biotech company committed to lowering costs, accelerating commercialization, and transforming the delivery of cell and gene therapies (CGTs), announces it has entered into an agreement to acquire the assets of Tamir Biotechnology, Inc. (“TamirBio”), including ranpirnase, TamirBio’s broad spectrum anti-viral platform.  The acquisition will be completed for total stock and cash consideration valued at approximately $19 million, based on the value of the stock at closing.  Orgenesis plans to combine ranpirnase with its co-developed Bioxome™ technology for enhanced payload delivery directly to cells.TamirBio is a clinical stage anti-viral therapeutics company engaged in the discovery and development of...